Geode Capital Management
ALLR

Geode Capital Management’s Allarity Therapeutics ALLR Stock Holding History

Geode Capital Management’s Portfolio ALLR Stock Details ALLR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$200K Sell
154,867
-35,526
-19% -$50.4K ﹤0.01% 3916
2026
Q1 		$208K Buy
190,393
+33,753
+22% +$36.3K ﹤0.01% 3899
2025
Q4 		$169K Buy
156,640
+4,713
+3% +$6.01K ﹤0.01% 3966
2025
Q3 		$240K Buy
151,927
+101,277
+200% +$127K ﹤0.01% 3863
2025
Q2 		$51.2K Buy
50,650
+16,729
+49% +$15.8K ﹤0.01% 4210
2025
Q1 		$31.8K Buy
+33,921
New +$35.1K ﹤0.01% 4273
2024
Q3 		– Sell
-3,411
Closed -$21.8K – 4536
2024
Q2 		$21.8K Buy
+3,411
New +$134K ﹤0.01% 4432
2023
Q1 		– Hold
0
– -$8K – 4804
2022
Q4 		– Hold
0
– – – 4856
2022
Q3 		– Hold
0
– – – 4837
2022
Q2 		– Hold
0
– – – 4828
2022
Q1 		– Hold
0
– – – 4913

Other funds holding ALLR

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MCM
Militia Capital Management Austin, Texas $3.37B AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Geode Capital Management's ALLR Position: Q2 2026 in Review

Geode Capital Management reduced its Allarity Therapeutics (ALLR) stake by 19% in Q2 2026, selling an estimated $50.4K and leaving 154,867 shares worth $200K. The position accounts for ﹤0.01% of the portfolio, ranked #3916.

Geode Capital Management first reported a position in ALLR in Q2 2024 and has held it in 7 quarters since. The position peaked at $240K in Q3 2025. 19 funds tracked by Wall St. Rank hold ALLR as of Q2 2026.

  • Geode Capital Management held 154,867 shares of Allarity Therapeutics worth $200K as of Q2 2026.
  • Geode Capital Management sold 35,526 Allarity Therapeutics shares in Q2 2026, an estimated $50.4K.
  • Allarity Therapeutics made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #3916 holding.
  • Geode Capital Management first reported a position in Allarity Therapeutics in Q2 2024 and has held it in 7 quarters since.
  • Geode Capital Management's Allarity Therapeutics position peaked at $240K in Q3 2025.
  • 19 funds tracked by Wall St. Rank held Allarity Therapeutics as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.